Tetrabenazine
Brand name: Tetrabenazine
Rank #470 of 500 drugs by total cost
$15.6M
Total Cost
6,326
Total Claims
$15.6M
Total Cost
353
Prescribers
$2,466
Cost per Claim
84
Beneficiaries
6,516
30-Day Fills
$44K
Avg Cost/Provider
18
Avg Claims/Provider
About Tetrabenazine
Tetrabenazine (sold as Tetrabenazine) was prescribed 6,326 times by 353 Medicare Part D providers in 2023, costing the program $15.6M. At $2,466 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 467 | Doxazosin Mesylate (Doxazosin Mesylate) | $15.7M | 729,878 |
| 468 | Prucalopride Succinate (Motegrity) | $15.7M | 22,068 |
| 469 | Ketorolac Tromethamine (Ketorolac Tromethamine) | $15.6M | 582,750 |
| 470 | Tetrabenazine (Tetrabenazine) | $15.6M | 6,326 |
| 471 | Avatrombopag Maleate (Doptelet) | $15.4M | 1,156 |
| 472 | Primidone (Primidone) | $15.3M | 450,535 |
| 473 | Fluocinonide (Fluocinonide) | $15.3M | 217,528 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology